China Medical Technologies To Announce Results For The Second Fiscal Quarter Ended September 30, 2011 On November 18, 2011
BEIJING, Nov. 1, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the second fiscal quarter ended September 30, 2011 ("2Q FY2011") before the U.S. market opens on November 18, 2011.
The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on November 18, 2011 ( 9:00 p.m. Beijing/ Hong Kong time on November 18, 2011).
The dial-in details for the live conference call are as follows:- U.S. Toll Free Number 1-866-519-4004- International Dial-in Number 1-718-354-1231Passcode: CMEDCALL A live webcast of the conference call will be available on http://ir.chinameditech.com. A replay of this webcast will be available for one month on this website. A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on November 19, 2011. The dial-in details for the replay are as follows: - U.S. Toll Free Number 1-866-214-5335- International Dial-in Number 1-718-354-1232Passcode: 22980262 A bout China Medical Technologies , Inc. China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its revenues in China through the sale of diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales personnel and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com. Contact Winnie YamTel: +852-2511-9808Email: IR@chinameditech.com SOURCE China Medical Technologies, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts